• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    7.90 Down 0.37(4.47%) Feb 5, 4:00PM EST
    |After Hours : 7.90 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:8.27
    Open:8.21
    Bid:7.61 x 500
    Ask:8.23 x 100
    1y Target Est:19.75
    Beta:1.772
    Next Earnings Date:29-Feb-16HALO Earnings announcement
    Day's Range:7.75 - 8.44
    52wk Range:7.49 - 25.25
    Volume:2,040,418
    Avg Vol (3m):1,454,300
    Market Cap:1.00B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    HALODown 4.47%1.00B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.34
    Quarterly EPS Est (Dec-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback